Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-choline PET/CT in Hormone Refractory Prostate Cancer
NCT00928252Phase 2Completed
- Sponsor
- The Queen's Medical Center
- Start
- Jun 2009
- Primary completion
- Jun 2016
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
A Phase 2 trial of fluorine-18 fluorocholine in prostate cancer (PCa), sponsored by The Queen's Medical Center. Started Jun 2009; status: completed.
02
Drugs
fluorine-18 fluorocholine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00928252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00928252.